NEW YORK, NY / ACCESSWIRE / October 4, 2016 / DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) today published a new blog post on The Chairman's Blog, written by the Company's Chairman and Chief Executive Officer, Jeffrey Bacha. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
In his new blog, Mr. Bacha highlights DelMar's focus on targeting DNA repair mechanisms to treat cancers that show resistance to currently available types of chemotherapy. He writes about how the Company's research of lead product VAL-083 has lead to an understanding of how it attacks a tumor's DNA and interacts differently with the body's DNA repair mechanisms compared with other chemotherapy options. Mr. Bacha goes on to discuss how this research may allow DelMar to address unmet medical needs in cancer patients resistant to current therapies. Read the full blog post from Mr. Bacha on TheChairmansBlog.com (Jeffrey Bacha - Targeting DNA Repair Mechanisms in the Fight Against Cancer).
About DelMar Pharmaceuticals, Inc.
DelMar Pharmaceuticals, Inc. was founded to develop and commercialize new cancer therapies in indications where patients are failing or have become intolerable to modern targeted or biologic treatments. The Company's lead drug in development, VAL-083, is currently undergoing clinical trials in the U.S. as a potential treatment for refractory glioblastoma multiforme. VAL-083 has been extensively studied by U.S. National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a novel mechanism of action that could provide improved treatment options for patients.
About TheChairmansBlog.com
TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com.
SOURCE: TheChairmansBlog.com
ReleaseID: 446468
